SCHEMBL1614320

SCHEMBL1614320

COc1ccc(S(=O)(=O)Nc2ccc(C=C3SC(=O)N(CC4(C)CCCCC4)C3=O)cc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.69
MTOR P42345 1/20 0.69
PRKAG1 P54619 1/20 0.65
PRKAA1 Q13131 1/20 0.65
PRKAB1 Q9Y478 1/20 0.65
KMT2A Q03164 5/20 0.52
MAPT P10636 4/20 0.52
MEN1 O00255 4/20 0.52
POLB P06746 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MCL1 Q07820 2/20 0.52
NPC1 O15118 2/20 0.52
USP2 O75604 1/20 0.52
MAPK1 P28482 1/20 0.48
CA9 Q16790 1/20 0.48
ALDH1A1 P00352 4/20 0.46
PPARG P37231 1/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614318 1.00 AURKA (0.69) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL2172045 0.90 AURKA (0.75) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL2172044 0.90 AURKA (0.75) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL2172230 0.89 AURKA (0.71) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL2172223 0.89 AURKA (0.71) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL2173036 0.89 AURKA (0.71) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL2173040 0.89 AURKA (0.71) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL1614597 0.88 AURKA (0.79) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL1614596 0.88 AURKA (0.79) AURKAMTORPRKAG1PRKAA1PRKAB1
SCHEMBL2174327 0.87 AURKA (0.68) AURKAMTORPRKAG1PRKAA1PRKAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 US claimed
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 EP claimed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 WO claimed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 US claimed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 US disclosed
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 EP disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 WO disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS PCK2, AK2, SIRT6 AURKA 1441/4885MTOR 251/4885PRKAG1 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.